Brian Park, PharmD

Drug Information Specialist https://www.thecardiologyadvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

General Cardiology

Semaglutide Injection Now Available as a Single Pen for Monthly Therapy

Brian Park, PharmD

April 8, 2021

Anavip contains venom-specific F(ab’)2 fragments of immunoglobulin G that bind and neutralize venom toxins.

Metabolic

Alirocumab Approved for Homozygous Familial Hypercholesterolemia

Brian Park, PharmD

April 6, 2021

The approval was based on data from the phase 3 ODYSSEY HoFH trial, which evaluated Praluent in 69 adults with HoFH who were on other LDL-C-lowering therapies.

General Cardiology

Real-World Data Demonstrate Effectiveness of Pfizer-BioNTech COVID-19 Vaccine

Brian Park, PharmD

March 17, 2021

The analysis was conducted when more than 80% of tested specimens in Israel were variant B.1.1.7 (UK variant).

General Cardiology

New Data Show Authorized Dose of Bamlanivimab-Etesevimab Cuts COVID-19 Hospitalizations, Death

Brian Park, PharmD

March 15, 2021

The new cohort included 769 high-risk patients aged 12 years and older with mild to moderate COVID-19.

General Cardiology

Vazalore, a Liquid-Filled Capsule Formulation of Aspirin, Gets FDA Approval

Brian Park, PharmD

March 8, 2021

Vazalore is indicated as a pain reliever, fever reducer, and for aspirin therapy indications.

Practice Management

FDA: Certain Factors May Affect Pulse Oximeter Accuracy

Brian Park, PharmD

March 5, 2021

According to the FDA’s safety communication, multiple factors may affect the accuracy of pulse oximeter readings, including poor circulation, skin pigmentation, skin thickness, skin temperature, current tobacco use, and use of fingernail polish.

Practice Management